What is KPV (10 mg)
KPV is a short α-MSH fragment research peptide widely studied for its role in inflammatory signaling and immune-response modulation. In controlled research settings, it’s commonly explored in gut-barrier integrity and mucosal repair models, as well as skin inflammation and tissue-healing pathways.
Potential Research Effects
• Down-regulation of pro-inflammatory signaling (often discussed with TNF-α, IL-6, NF-κB pathways)
• Support for intestinal barrier integrity in leaky-gut/colitis-type research models
• Immune modulation research (balancing response rather than suppressing it)
• Support for mucosal healing and tissue-repair outcomes in controlled models
• Research interest in skin inflammation and wound-healing pathway studies
• Potential reduction of oxidative-stress markers in preclinical research
Includes 10 sterile research-use syringes with every vial order.
Cybergen Peptides: Research Use Disclaimer
All products offered by Cybergen Peptides are intended solely for laboratory, educational, and scientific research purposes.
These materials are supplied for in-vitro research only (“in glass”) and are
not intended for human or animal consumption, medical use, or diagnostic applications.
Cybergen Peptides compounds are not drugs, medicines, or dietary supplements and have
not been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency.
They are not intended to diagnose, treat, cure, or prevent any disease.
Any form of bodily introduction, clinical testing, or therapeutic application is strictly prohibited.
